Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $441 Billion
  • Q1 2024

Adar1 Capital Management, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $441 Billion distributed in 261 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ea Series Trust with a value of $33.9B, Roivant Sciences Ltd. with a value of $29.4B, Alnylam Pharmaceuticals, Inc. with a value of $26.9B, Protagonist Therapeutics, Inc with a value of $22.7B, and Cytokinetics Inc with a value of $22.4B.

Examining the 13F form we can see an increase of $161B in the current position value, from $280B to 441B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $441 Billion
Healthcare: $315 Billion
ETFs: $45.7 Billion
Communication Services: $4.56 Billion
Basic Materials: $2.16 Billion
Financial Services: $1.49 Billion
Technology: $351 Million
Utilities: $234 Million
Consumer Cyclical: $168 Million
Other: $152 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Ea Series Trust
-
$33.9 Billion 7.68% of portfolio
-
Q1 2024 New
$7.63B
$29.4 Billion 6.68% of portfolio
2,791,870
Q1 2024 Added 122.18%
$29.5B
$26.9 Billion 6.11% of portfolio
180,145
Q1 2024 Added 1,796.26%
$1.56B
$22.7 Billion 5.16% of portfolio
785,655
Q1 2024 Added 291.15%
$4.98B
$22.4 Billion 5.08% of portfolio
319,510
Q1 2024 Added 246.98%
$1.18B
$22.4 Billion 5.08% of portfolio
338,243
Q1 2024 Reduced 50.86%
$11.8B
$21.9 Billion 4.97% of portfolio
721,301
Q1 2024 Reduced 45.43%
$3.47B
$17 Billion 3.86% of portfolio
549,804
Q1 2024 Added 196.97%
$203M
$13.3 Billion 3.02% of portfolio
902,350
Q1 2024 Added 64.24%
$7.58B
$7.34 Billion 1.67% of portfolio
48,584
Q1 2024 Added 5.88%
$457M
$5.35 Billion 1.21% of portfolio
2,074,183
Q1 2024 Reduced 40.21%
$0
$5.06 Billion 1.15% of portfolio
3,954,857
Q1 2024 Added 7,786.53%
$15.7B
$4.93 Billion 1.12% of portfolio
31,505
Q1 2024 Added 1,453.5%
$3.97B
$4.24 Billion 0.96% of portfolio
156,600
Q1 2024 New
Helix Acquisition Corp Ii
-
$4.2 Billion 0.95% of portfolio
-
Q1 2024 New
$13.8B
$4.03 Billion 0.91% of portfolio
31,105
Q1 2024 Added 285.82%
Achieve Life Sciences Inc
-
$3.98 Billion 0.9% of portfolio
-
Q1 2024 New
$0
$3.78 Billion 0.86% of portfolio
177,200
Q1 2024 New
$273M
$3.33 Billion 0.76% of portfolio
586,984
Q1 2024 New
$1.1B
$3.3 Billion 0.75% of portfolio
180,911
Q1 2024 New
Q32 Bio Inc
-
$3.2 Billion 0.73% of portfolio
-
Q1 2024 New
$311M
$3.21 Billion 0.73% of portfolio
339,825
Q1 2024 Reduced 46.69%
$213M
$3.1 Billion 0.7% of portfolio
456,588
Q1 2024 New
$0
$2.98 Billion 0.68% of portfolio
32,500
Q1 2024 Added 1.56%
$157B
$2.95 Billion 0.67% of portfolio
106,342
Q1 2024 Added 511.16%
-
$2.74 Billion 0.62% of portfolio
-
Q1 2024 Added 9.96%
$0
$2.72 Billion 0.62% of portfolio
54,000
Q1 2024 Added 10.2%
$0
$2.71 Billion 0.61% of portfolio
24,500
Q4 2023 New
Solid Biosciences Inc
-
$2.71 Billion 0.61% of portfolio
-
Q1 2024 Added 20,220.4%
$0
$2.67 Billion 0.6% of portfolio
53,000
Q1 2024 Reduced 5.36%
Cellectar Biosciences Inc
-
$2.56 Billion 0.58% of portfolio
-
Q1 2024 Reduced 53.37%
-
$2.45 Billion 0.56% of portfolio
-
Q1 2024 Reduced 5.58%
$839M
$2.34 Billion 0.53% of portfolio
206,856
Q1 2024 New
$115B
$2.21 Billion 0.5% of portfolio
2,300
Q1 2024 New
Ibio Inc
-
$2.19 Billion 0.5% of portfolio
-
Q1 2024 New
$38.1B
$2.16 Billion 0.49% of portfolio
37,400
Q1 2024 Reduced 35.52%
$19.4M
$2.1 Billion 0.48% of portfolio
1,204,820
Q1 2024 New
$3.52B
$1.96 Billion 0.45% of portfolio
60,763
Q1 2024 Reduced 54.7%
$0
$1.93 Billion 0.44% of portfolio
47,684
Q1 2024 Reduced 22.17%
$1.33B
$1.96 Billion 0.44% of portfolio
26,800
Q1 2024 New
Spyre Therapeutics Inc
-
$1.88 Billion 0.43% of portfolio
-
Q1 2024 Added 668.63%
$1.16B
$1.72 Billion 0.39% of portfolio
63,586
Q1 2024 Added 3,079.3%
$46.6M
$1.59 Billion 0.36% of portfolio
926,929
Q1 2024 Reduced 13.19%
$208M
$1.52 Billion 0.35% of portfolio
292,850
Q1 2024 New
$4.44B
$1.51 Billion 0.34% of portfolio
25,700
Q1 2024 New
$860B
$1.45 Billion 0.33% of portfolio
1,865
Q1 2024 New
$18.3B
$1.43 Billion 0.33% of portfolio
101,626
Q1 2024 Reduced 8.71%
$0
$1.3 Billion 0.29% of portfolio
816,581
Q1 2024 New
$3.67B
$1.18 Billion 0.27% of portfolio
14,401
Q1 2024 Reduced 94.33%

Summary

  • Portfolio
  • No. of Stocks 261
  • Current Value $441 Billion
  • Prior Value $280 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 119 stocks
  • Additional Purchases 35 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 44 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email